Skip Navigation

Cardiovascular Research 2004 61(3):559-569; doi:10.1016/j.cardiores.2003.10.018
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tschöpe, C.
Right arrow Articles by Walther, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tschöpe, C.
Right arrow Articles by Walther, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction

Carsten Tschöpe*,a, Frank Spillmanna, Christine Altmanna, Matthias Kocha, Dirk Westermanna, Nasser Dhayata, Sameer Dhayata, Jean-Loup Bascandsb, Lajos Gerac, Sigrid Hoffmannd, Heinz-Peter Schultheissa and Thomas Walthera

aDepartment of Cardiology and Pneumology, Charité—University Medicine, Campus Benjamin Franklin, Hindenburgdamm 30, D-12220 Berlin, Germany
bINSERM U388, Institut Louis Bugnard, Toulouse, France
cBiochemistry Department, University of Colorado, Denver, CO, USA
dDepartment of Medicine, University Hospital Mannheim, University Heidelberg, Mannheim, Germany

* Corresponding author. Tel.: +49-30-8445-2343; fax: +49-30-78717823. ctschoepe{at}yahoo.com

Objective: To investigate the role of the bradykinin B1 receptor (B1R) on the angiotensin receptor AT1 blockade-dependent cardioprotective effects, we studied the B1R regulation in wild-type rats treated with the AT1 antagonist, irbesartan (IRB), and also in transgenic rats with cardiac overexpression of the human AT1 (TGR-{alpha}MHCAT1) after induction of myocardial infarction (MI). In addition, we treated wild-type rats with IRB and/or the B1R antagonist, B9958, and determined the left ventricular (LV) function. Methods: Untreated, IRB (50 mg/kg/day/p.o.), B9958 (0.1 mg/kg/48 h/s.c.), and IRB/B9958-treated Sprague–Dawley rats were submitted to a permanent occlusion of the left descending coronary artery. Six days and three weeks after induction of MI, the LV function was characterized by using a Millar-tip catheter. Myocardial AT1- and B1-mRNA expression were analyzed by RNase-protection assays, B1R protein density by immunohistochemistry. Results: At both time points, LV function had improved by almost 50% after treatment with IRB but remained unchanged in TGR-{alpha}MHCAT1 after induction of MI compared to their untreated controls. The beneficial effect of IRB was reversed by co-treatment with B9958. The B1R antagonist treatment alone had no effect. A cross-talk between AT1 and B1R was also indicated by an up-regulation of B1R after treatment with IRB on protein and RNA level, while AT1 overexpression reduced B1R expression after induction of MI. Conclusion: These results indicate that the mechanisms of B1R regulation are influenced by the AT1 receptor. Thus, we are able to demonstrate for the first time that the B1R contributes to the cardio-beneficial effects of AT1 blockade.

KEYWORDS Hemodynamics; Infarction; Renin–angiotensin system; Signal transduction

Time for primary review 00 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al.
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
J. Immunol., May 15, 2008; 180(10): 6954 - 6961.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.